We are passionate about delivering transformational, science-led innovation that is distinctly accessible for all. Alzheimer's, Parkinson's, heart disease, migraine, and COVID-19 don't discriminate based on where you live or how much you make, and we believe medicine shouldn’t either.
Our team is comprised of leaders in neurobiology, drug and vaccine development, infectious disease, and disruptive ideas.
Jean-Cosme Dodart, PhD
SVP Research
Amy Fix
Chief Regulatory Officer
Jon Harrison
Chief Government Officer
Mei Mei Hu, JD
Chief Executive Officer
Mark Joinnides
Chief of Staff
John Krayacich
Chief Business Officer
Dario Mirski, MD
SVP Neuro / Chronic Diseases
René Paula Molina
General Counsel and Secretary
Ulo Palm, MD, PhD
Chief Medical Officer
Jason Pesile
SVP Finance & Accounting
Lou Reese
Co-Founder and Executive Chairman of the Board
Dwayne Soisson
VP Operations
Lou Reese
Co-Founder and Executive Chairman of the Board
Katherine Eade, JD
Director
Mei Mei Hu, JD
Chief Executive Officer
Landon Ogilvie
Director
George Hornig
Director, Audit Committee Chair
Peter Powchik
Director
Gaby Toledano
Director, Compensation Committee Chair
James Smith
Director
Peter H. Diamandis, MD
Director, Nominating And Corporate Governance Committee Chair
Thomas P. Monath, MD
Crozet BioPharma
Wayne Koff, PhD
NIH, Human Vaccines Project
Stanley A. Plotkin, MD
Johns Hopkins, Vaxconsult
Brad Boeve, MD
Mayo Clinic
Richard Mohs, Ph.D
Global Alzheimer’s Platform
Jeffrey Cummings, MD, ScD
Cleveland Clinic
Eric Reiman M.D
Banner Research
Nick Fox, MD
UCL Neurology
Stephen D. Silberstein, M.D.
Thomas Jefferson University
Kausik K. Ray, M.D.
Imperial College London, European Atherosclerosis Society
Stephen Nicholls, Ph.D.
Monash University Victorian Heart Institute
Frederick Raal, Ph.D.
University of the Witwatersrand
Dirk von Lewinski, M.D.
Medical University of Graz
Thomas Fleming, Ph.D.
University of Washington Biostatistics
Parviz Ghahramani, Ph.D.
Inncelerex